CCI
ARRY

Columbus Circle Investors’s Array Biopharma Inc ARRY Stock Holding History

Columbus Circle Investors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-553,980
Closed -$25.7M – 200
2019
Q2 		$25.7M Sell
553,980
-564,207
-50% -$15.8M 0.69% 59
2019
Q1 		$27.3M Sell
1,118,187
-210,215
-16% -$4.38M 0.69% 64
2018
Q4 		$18.9M Sell
1,328,402
-234,164
-15% -$3.55M 0.54% 79
2018
Q3 		$23.8M Sell
1,562,566
-65,130
-4% -$998K 0.47% 84
2018
Q2 		$27.3M Buy
1,627,696
+493,964
+44% +$7.86M 0.56% 70
2018
Q1 		$18.5M Buy
1,133,732
+838,412
+284% +$13.4M 0.38% 97
2017
Q4 		$3.78M Buy
295,320
+51,386
+21% +$584K 0.07% 160
2017
Q3 		$3M Buy
243,934
+30,509
+14% +$283K 0.05% 202
2017
Q2 		$1.79M Sell
213,425
-171,274
-45% -$1.4M 0.03% 209
2017
Q1 		$3.44M Sell
384,699
-146,107
-28% -$1.55M 0.05% 209
2016
Q4 		$4.67M Sell
530,806
-459,164
-46% -$3.38M 0.06% 191
2016
Q3 		$6.68M Buy
989,970
+472,774
+91% +$1.83M 0.07% 194
2016
Q2 		$1.84M Sell
517,196
-338,634
-40% -$1.1M 0.02% 210
2016
Q1 		$2.52M Buy
855,830
+158,708
+23% +$476K 0.02% 220
2015
Q4 		$2.94M Sell
697,122
-215,786
-24% -$985K 0.02% 235
2015
Q3 		$4.16M Sell
912,908
-18,481
-2% -$110K 0.03% 230
2015
Q2 		$6.71M Sell
931,389
-19,256
-2% -$142K 0.05% 230
2015
Q1 		$7.01M Sell
950,645
-341,783
-26% -$2.43M 0.05% 227
2014
Q4 		$6.11M Buy
1,292,428
+535,050
+71% +$2.12M 0.04% 227
2014
Q3 		$2.7M Buy
757,378
+142,263
+23% +$561K 0.02% 218
2014
Q2 		$2.81M Buy
615,115
+131,364
+27% +$543K 0.02% 242
2014
Q1 		$2.27M Buy
483,751
+235,346
+95% +$1.18M 0.02% 250
2013
Q4 		$1.25M Sell
248,405
-179,246
-42% -$976K 0.01% 264
2013
Q3 		$2.66M Buy
+427,651
New +$2.54M 0.02% 266

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Columbus Circle Investors's ARRY Position: Q3 2019 in Review

Columbus Circle Investors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 553,980 shares — an estimated $25.7M sold.

Columbus Circle Investors first reported a position in ARRY in Q3 2013 and held it in 24 quarters. The position peaked at $27.3M in Q2 2018. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Columbus Circle Investors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Columbus Circle Investors sold 553,980 Array Biopharma Inc shares in Q3 2019, an estimated $25.7M.
  • Columbus Circle Investors first reported a position in Array Biopharma Inc in Q3 2013 and held it in 24 quarters.
  • Columbus Circle Investors's Array Biopharma Inc position peaked at $27.3M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Columbus Circle Investors's 13F filing for Q3 2019, filed 29 Oct 2019.